Mark E. Dudley
- Immunology top 0.02%
- Immunotherapy and Immune Responses 73
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 16
- Oncology top 0.01%
- CAR-T cell therapy research 90
- Cancer Immunotherapy and Biomarkers 17
- Genetics top 0.1%
- Virus-based gene therapy research 36
- Molecular Biology top 0.5%
- vaccines and immunoinformatics approaches 8
- CRISPR and Genetic Engineering 7
- Biotechnology top 0.5%
- Co-authors
- Steven A. RosenbergNicholas P. RestifoJohn R. WunderlichJames C. YangRichard A. MorganPaul F. RobbinsRichard M. SherryJames Chih‐Hsin Yang
- Cited by
- ImmunologyOncologyGenetics
- Journals
- Journal of Immunotherapy (16 papers)The Journal of Immunology (14 papers)Clinical Cancer Research (10 papers)
- Partner nations
- United StatesMalaysiaCanada
In The Last Decade
Mark E. Dudley
112 papers receiving 28.7k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Immunology 20.2k
- Oncology 23.5k
- Genetics 5.6k
- Molecular Biology 6.8k
- Biotechnology 791
Countries citing papers authored by Mark E. Dudley
This map shows the geographic impact of Mark E. Dudley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Dudley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Dudley more than expected).
Fields of papers citing papers by Mark E. Dudley
This network shows the impact of papers produced by Mark E. Dudley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Dudley. The network helps show where Mark E. Dudley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Dudley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cellsbreakdown → | 2015 | 506 |
| 2 | 2015 | 332 | |
| 3 | 2014 | 304 | |
| 4 | 2014 | 39 | |
| 5 | A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Responsebreakdown → | 2014 | 585 |
| 6 | 2012 | 73 | |
| 7 | Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapybreakdown → | 2011 | 1603 |
| 8 | 2010 | 245 | |
| 9 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimensbreakdown → | 2008 | 1017 |
| 10 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytesbreakdown → | 2006 | 1961 |
| 11 | 2006 | 240 | |
| 12 | 2004 | 80 | |
| 13 | 2004 | 45 | |
| 14 | 2004 | 375 | |
| 15 | 2003 | 175 | |
| 16 | 2002 | 68 | |
| 17 | 2001 | 47 | |
| 18 | 2000 | 138 | |
| 19 | Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomabreakdown → | 1998 | 1480 |
| 20 | 1996 | 50 |
About Mark E. Dudley
Mark E. Dudley is a scholar working on Immunology, Oncology and Genetics, having authored 114 papers that have together received 29.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (90 papers), Immunotherapy and Immune Responses (73 papers), Virus-based gene therapy research (36 papers), Immune Cell Function and Interaction (26 papers), Cancer Immunotherapy and Biomarkers (17 papers), T-cell and B-cell Immunology (16 papers), vaccines and immunoinformatics approaches (8 papers) and CRISPR and Genetic Engineering (7 papers). The work is most often cited by research in Immunology (20.2k citations), Oncology (23.5k citations) and Genetics (5.6k citations). Mark E. Dudley has collaborated with scholars based in United States, Malaysia and Canada. Frequent co-authors include Steven A. Rosenberg, Nicholas P. Restifo, John R. Wunderlich, James C. Yang, Richard A. Morgan, Paul F. Robbins, Richard M. Sherry, James Chih‐Hsin Yang, Donald E. White and Carolyn M. Laurençot. Their work appears in journals such as Journal of Immunotherapy, The Journal of Immunology, Clinical Cancer Research, Blood and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.